Status:
COMPLETED
European Study of Cardiovascular Risk
Lead Sponsor:
AstraZeneca
Conditions:
Cardiovascular Risk Factors
Hyperlipidemia
Eligibility:
All Genders
50+ years
Brief Summary
The main objective of this study is to describe the management of patients with cardiovascular risk factors in primary prevention among different European countries. The patient's participation consi...
Eligibility Criteria
Inclusion
- Provision of informed consent.
- Patients 50+ years old, with at least one additional CV risk factor (with no previous CV event or hospitalisation for a CV event) from Primary Care or hospital outpatient clinic.
Exclusion
- Subjects who are unwilling or unable to provide informed consent
- Previous CV disease event or hospitalisation for a CV event
- Current participation in a clinical trial
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2009
Estimated Enrollment :
7200 Patients enrolled
Trial Details
Trial ID
NCT00882336
Start Date
May 1 2009
End Date
October 1 2009
Last Update
October 29 2009
Active Locations (775)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Alland, Austria
2
Research Site
Bad Vöslau, Austria
3
Research Site
Baden, Austria
4
Research Site
Bierbaum am Auersbach, Austria